Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy
Authors:
- 21 February 2023
- journal article
- review article
- Published by Wiley in Small Methods
- Vol. 7 (5) , e2201401
Abstract
In cancer treatment, traditional radiotherapy (RT) is routinely conducted in local tumors and limited by radioresistance, while recently emerged immunotherapy is confronted with low response rate, high cost, and cytokine release syndrome. Logically, the combination of the two therapeutic modalities into radioimmunotherapy is promising to complement with each other for systemic elimination of cancer cells with high specificity, efficiency, and safety. Especially, RT‐induced immunogenic cell death (ICD) plays an imperative role in radioimmunotherapy to evoke systemic immune response against cancer, including elevating the immunity of tumor antigens, recruiting and activating antigen‐presenting cells, and priming cytotoxic T lymphocytes for tumoral infiltration and cancer cell eradication. This review first retrospects the origin and concept of ICD, summarizes the major damage‐associated molecular patterns and signaling pathways, and highlights the characteristics of RT‐induced ICD. Subsequently, therapeutic strategies enhancing RT‐induced ICD for radioimmunotherapy are reviewed from the perspectives of enhancing RT itself, combination with other treatments, and stimulating the holistic immune system. On the basis of these published research and underlying mechanism, this work attempts to forecast possible directions for RT‐induced ICD enhancement to promote clinical applications.Keywords
Funding Information
- National Natural Science Foundation of China (U1932208, 32171382, 32000990)
- Natural Science Foundation of Jiangsu Province (BK20190946)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 131 references indexed in Scilit:
- Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine releaseJournal of Experimental Medicine, 2012
- HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4Journal of Experimental Medicine, 2012
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathThe EMBO Journal, 2012
- The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive ImmunityCancer Research, 2011
- Circulating mitochondrial DAMPs cause inflammatory responses to injuryNature, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearanceNature, 2009
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 AntibodyClinical Cancer Research, 2009
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007